By Joanne Van Zuidam | July 26, 2017Technology that Supports Clinical Research: A Q&A with Oracle’s Steve Rosenberg
By Joanne Van Zuidam | July 21, 2017Trial Launched to see if Lifestyle Choices will Lower Risk of Alzheimer’s
By Joanne Van Zuidam | July 14, 2017Positive Results for Emicizumab in Phase III Studies in Hemophilia A with Inhibitors
By Joanne Van Zuidam | July 6, 2017Glenmark Pharmaceuticals Undergoes Transition to Meet Unmet Medical Needs: A Q&A with Fred Grossman, DO, FAPA
By Joanne Van Zuidam | June 30, 2017FDA Delivering 90-Day Guarantee on Orphan Drug Designation Requests
By Joanne Van Zuidam | June 23, 2017Roche’s Top-Selling Cancer Drug Approved in Faster Injection Form
By Joanne Van Zuidam | June 23, 2017TIL Candidate Shows Potential in Metastatic Melanoma Based on Interim Data
By Joanne Van Zuidam | June 16, 2017New Outcomes Study Planned for Diabetes Drug with Potential in Treating Kidney Disease
By Joanne Van Zuidam | June 13, 2017ADA 2017: Canagliflozin Significantly Reduces Risk of Cardiovascular Events
By Joanne Van Zuidam | June 12, 2017ADA 2017: Investigational Drug for Knee Osteoarthritis Avoids Significant Rise in Blood Glucose in Type 2 Diabetes Patients
By Joanne Van Zuidam | June 6, 2017ASCO 2017: Investigational Agent Improves Survival Outcomes for EGFR-Positive Lung Cancer
By Joanne Van Zuidam | June 5, 2017ASCO 2017: Olaparib Slows Tumor Growth in Advanced BRCA-Related Cancer
